Medical News

RSS

$27 million received to speed new treatments for disabling neurological disorder

The Johns Hopkins University School of Medicine has announced receipt of a five-year, $27 million gift earmarked to fast-track the development of therapies to treat tumors associated with neurofibromatosis type 1 (NF1), a common and often debilitating neurogenetic disorder that causes tumors called plexiform neurofibromas to grow on nerves anywhere in the body.

11 Jun 2012

Distinct cancer 'signatures' may help predict response to estrogen-lowering therapy

Decoding the DNA of patients with advanced breast cancer has allowed scientists to identify distinct cancer "signatures" that could help predict which women are most likely to benefit from estrogen-lowering therapy, while sparing others from unnecessary treatment.

11 Jun 2012

Rapid test to identify patients not responding to painkiller tramadol

French researchers have found a way to identify quickly the 5-10% of patients in whom the commonly used painkiller, tramadol, does not work effectively. A simple blood test can produce a result within a few hours, enabling doctors to switch a non-responding patient on to another painkiller, such as morphine, which will be able to work in these patients.

11 Jun 2012

New liquid stable homocysteine kit from Randox

The new liquid stable homocysteine kit from Randox provides a convenient and accurate method for the determination of homocysteine in human serum and plasma. Homocysteine is a potential indicator of a number of disease markers and should therefore be an integral part of a laboratory’s testing menu.

From Randox Laboratories Ltd. 11 Jun 2012

OOCE chooses eClinicalWorks comprehensive EHR solution

ClinicalWorks, a market leader in ambulatory clinical systems, today announced that Ohio Orthopedic Center of Excellence, has chosen eClinicalWorks comprehensive electronic health records (EHR) solution for its 59 providers across multiple locations. Use of this technology will help improve practice speed and efficiency.

11 Jun 2012

Positive results from Cara’s CR845 Phase II study on acute post-operative pain

Cara Therapeutics, Inc. today announced positive results from a Phase II study for the treatment of acute post-operative pain with its novel, peptide-based, peripherally-acting kappa opioid agonist, CR845.

11 Jun 2012

Powerful new tools can study glycans’ function

Scientists at The Scripps Research Institute have developed chemical compounds that can make key modifications to common sugar molecules ("glycans"), which are found on the surface of all cells in our body. The new study presents powerful new tools for studying these molecules' function, for example in cell signaling and immunity, and for investigating new treatments for chronic inflammation, autoimmune diseases, cancer metastasis, and related conditions.

11 Jun 2012

Sagard Capital to acquire IntegraMed

IntegraMed America, Inc., a leader in developing, marketing and managing specialty healthcare facilities in the fertility and vein care markets, announced today that it has entered into a definitive agreement to be acquired by affiliates formed by Sagard Capital Partners, L.P., an investment fund and IntegraMed shareholder, for $14.05 per share in cash, or a total equity purchase price of $169.5 million.

11 Jun 2012

Knome announces start of early technology access program for knomeCLINIC

Knome, Inc., today announced the start of its early technology access program for knomeCLINIC, a software suite designed to help medical researchers and clinicians interpret human genomes for biological relevance.

11 Jun 2012

Advance's Summer College Institute to take place from August 5-12

Advance LA announced today its newest program, The Summer College Institute. This innovative program will take place August 5-12, 2012, on the campus of American Jewish University in Los Angeles.

11 Jun 2012

Mazor Robotics successfully completes first robot-guided brain surgical procedures

Mazor Robotics Ltd., a developer of innovative surgical robots and complementary products, today announced the successful completion of the first robot-guided brain surgical procedures, which were performed with Mazor Robotics' technology.

11 Jun 2012

First Edition: June 11, 2012

Today's headlines feature reports that UnitedHealthcare plans to honor some health law provisions regardless of what the Supreme Court decides.

11 Jun 2012

POI signs multi-year contract for DATATRAK ONE products

DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced Pharm-Olam International (POI), a global Contract Research Organization (CRO), signed a multi-year, multi-million dollar contract standardizing on the cloud-based unified clinical research platform, DATATRAK ONE.

11 Jun 2012

Acacia subsidiary announces acquisition of 7 medtech patent portfolios

Acacia Research Corporation announced today that a subsidiary has acquired 7 medtech patent portfolios comprised of over 150 patents and pending applications relating to medical devices, biologics and diagnostic techniques.

11 Jun 2012

BioSante to initiate two new LibiGel Phase III efficacy trials in FSD, HSDD

BioSante Pharmaceuticals, Inc., announced today that the Company plans to initiate two new LibiGel Phase III efficacy trials. This decision is based on an extensive analysis of previous efficacy data, consultation with key opinion leaders (KOLs) in female sexual dysfunction, testosterone therapy and placebo effects, as well as a meeting with the U.S. Food and Drug Administration (FDA).

11 Jun 2012

FDA clears Nexstim’s new module for use with NBS System

Nexstim Oy, a medical device company, announced today that the U.S. Food and Drug Administration (FDA) has cleared the NexSpeech module for use with the Navigated Brain Stimulation (NBS) System.

11 Jun 2012

Ampio’s CRO completes Optina clinical trial for DME

Ampio Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, whose lead drugs treat inflammatory diseases, including osteoarthritis and complications of Diabetes Mellitus such as diabetic macular edema (and others) announced today that it's CRO has completed analysis of the primary end point in the Optina clinical trial for DME conducted at St Michael Diabetes Hospital in Toronto Canada.

11 Jun 2012

UMI, Toshiba partner to sell ultrasound systems in the U.S.

To meet the increased need for advanced ultrasound equipment, Toshiba America Medical Systems, Inc. has partnered with United Medical Instruments (UMI), a worldwide provider of new and pre-owned ultrasound systems, parts and transducers, to sell Toshiba's ultrasound systems to the private physician office and clinic market in the U.S.

11 Jun 2012

Short sleep periods increase risk of stroke in normal-weight adults

Habitually sleeping less than six hours a night significantly increases the risk of stroke symptoms among middle-age to older adults who are of normal weight and at low risk for obstructive sleep apnea (OSA), according to a study of 5,666 people followed for up to three years.

11 Jun 2012

Data from first feasibility study of artificial pancreas system

Results from the first feasibility study of an advanced first-generation artificial pancreas system were presented today at the 72nd Annual American Diabetes Association Meeting in Philadelphia. Findings from the study indicated that the Hypoglycemia-Hyperglycemia Minimizer (HHM) System was able to automatically predict a rise and fall in blood glucose and correspondingly increase and/or decrease insulin delivery safely.

11 Jun 2012